Acrivon Therapeutics, Inc. ACRV
Set alert
1.67 USD +0.06 +3.73%
As of Nov 3, 10:13 AM ET
1.61 Day range 1.67
1.27 52-week range 3.56
- YTD
- -30.71%
- 1 year
- -28.33%
- Open
- 1.61
- Prev close
- 1.61
- Mkt cap
- 70.49M
- Vol
- 39.94K
- Avg vol
- 294.81K
- EPS
- -1.88
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.61
- High
- 1.67
- Forward P/E
- -2.31
- Beta
- 0.00
- Short ratio
- 15.38
- Inst. own
- 75.98%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 13, 2024
- 50-d avg
- 7.44
- 200-d avg
- 7.65
- 1y target
- 21.11
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -84.11M | -89.20M | -67.10M | -32.66M | -16.18M | |
| -77.91M | -80.56M | -60.39M | -31.17M | -16.24M | |
| -2.02 | -2.38 | -2.74 | -7.56 | -9.32 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 41.70M | 40.02M | 36.43M | 29.91M | 99.99M | |
| 129.72M | 196.59M | 138.26M | 181.23M | 106.59M | |
| 17.20M | 19.80M | 17.07M | 10.75M | 7.88M | |
| 2.71M | 3.65M | 4.64M | 4.96M | 5.63M | |
| 112.52M | 176.79M | 121.19M | 170.47M | -23.81M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -63.66M | -65.67M | -42.64M | -30.12M | -13.98M | |
| 66.10M | -51.77M | 50.72M | -141.68M | -238.00K | |
| -749.00K | 121.03M | -1.55M | 101.71M | 112.22M | |
| -1.67M | -2.77M | -1.29M | -2.17M | -238.00K | |
| 1.69M | 3.59M | 6.52M | -70.08M | 98.00M |